Opiate Receptors and Antagonists From Bench to Clinic /
The evolution in our understanding of Opioid receptors and their subtypes is intimately linked to the development of new pharmacological treatments for diseases and disorders as diverse as addiction, self-injurious behavior, pain, cancer, inflammation, eating disorders, traumatic injury, pruritis an...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Totowa, NJ :
Humana Press,
2009.
|
| Σειρά: | Contemporary Neuroscience
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Opioid Receptors
- Ultra-Low-Dose Opioid Antagonists Enhance Opioid Analgesia and Reduce Tolerance
- Upregulation of Opioid Receptors
- Imaging Human Brain Opioid Receptors: Applications to Substance Use Disorders
- Opioid Receptor Antagonist-Mediated Signaling in the Immune System
- Opioid Antagonists: Chemistry and Pharmacology
- The Chemistry and Pharmacology of ?-Opioid Antagonists
- Medicinal Chemistry of Kappa Opioid Receptor Antagonists
- The Chemistry and Pharmacology of Delta Opioid Antagonists
- Novel Opioid Antagonists with Mixed/Dual Selectivity
- Experimental Utility and Clinical Potential of Irreversible Opioid Antagonists
- Methylnaltrexone: A Peripherally Acting Opioid Antagonist
- Substance Abuse
- Opioid Antagonist Effects in Animal Models Related to Opioid Abuse: Drug Discrimination and Drug Self-Administration
- Naltrexone for Initiation and Maintenance of Opiate Abstinence
- Ultra-Low-Dose Naltrexone Decreases Dependence and Addictive Properties of Opioids
- Can a Combination Formulation Containing a Neutral Opiate Antagonist Decrease the Abuse of ?-Agonist Opiates
- Effects of Opioid Antagonists on the Abuse-Related Effects of Psychomotor Stimulants and Nicotine
- Potential Use of Opioid Antagonists in the Treatment of Marijuana Abuse and Dependence
- Naltrexone in Smoking Cessation: A Review of the Literature and Future Directions
- Alcohol and Ingestive Behaviors
- Opioid Antagonists and Ethanol's Ability to Reinforce Intake of Alcoholic Beverages: Preclinical Studies
- Clinical Use of Opioid Antagonists in the Treatment of Alcohol Dependence
- Preclinical Effects of Opioid Antagonists on Feeding and Appetite
- CNS Opiate Systems and Eating Disorders
- Behavioral Disorders
- Potential Utility of Kappa Ligands in the Treatment of Mood Disorders
- Opioid Antagonists in the Treatment of Pathological Gambling and Kleptomania
- Efficacy of Opioid Antagonists in Attentuating Self-Injurious Behavior
- Pharmacotherapeutic Effects of Opioid Antagonists in Alcohol-Abusing Patients with Schizophrenia
- Medical Indications
- Current Issues in the Use of Opioid Antagonists (Naltrexone for Opiate Abuse: A Re-Educational Tool as Well as an Effective Drug)
- Emergency Room Use of Opioid Antagonists in Drug Intoxication and Overdose
- Kappa-Opioid Antagonists as Pruritogenic Agents
- Clinical Effect of Opioid Antagonists on Clinical Pruritus
- Effects of Opioid Antagonists on l-DOPA-Induced Dyskinesia in Parkinson's Disease
- Endocrine Effects of Opioid Antagonists
- Opioid Antagonists in Traumatic Shock: Animal and Human Studies
- The Efficacy of Opioid Antagonists Against Heatstroke-Induced Ischemia and Injury in Rats
- A Review of the Opioid System in Cancer Patients and Preliminary Results of Opioid Antagonists in the Treatment of Human Neoplasms
- Nonclinical Pharmacology of VIVITROL®: A Monthly Injectable Naltrexone for the Treatment of Alcohol Dependence
- The Development of Sustained-Release Naltrexone and Clinical Use in Treating Opiate Dependence
- The Development of ProNeura Technology for the Treatment of Addictions
- Development of Opioid Transdermal Delivery Systems
- Intranasal Naloxone for Treatment of Opioid Overdose.
